Duplicate Therapy Database™

Improves Clinical Outcomes by Avoiding Unnecessary Therapeutic Duplication

PREVENTS DRUG DUPLICATION
Duplicate Therapy Database™ equips health care providers with accurate, timely alerts to potential duplications in drug therapy. Information in the database is drug-specific, comprehensive and Screens for drugs with similar primary indications or active ingredients.

FEATURES

• Therapeutic duplications for products used for single and multiple therapeutic purposes
• Ingredient duplications for single and multiple ingredient products
• OTC medication duplications
• Codes identifying duplication class, be it an ingredient, mechanism of action or therapeutic indication
• Significance codes to indicate presence of abuse potential
• Duplication Allowance indicator to specify the number of acceptable duplications before providing an alert

BENEFITS

FOR HEALTH CARE FACILITIES

• Supports Drug Utilization Review (DUR)
• Identifies duplications related to ingredients, actions or indications
• Screens for drug duplications with abuse potential
• Improves both clinical and financial outcomes by avoiding toxic or unnecessary therapies
• Reduces risks by protecting against unintentional drug duplication associated with the combined use of prescription and OTC medications
• Enhances the safety of patients being treated by multiple physicians
• Click here to download the PDF

FOR HEALTH CARE PROVIDERS

• Supports Drug Utilization Review (DUR)
• Identifies duplications related to ingredients, actions or indications
• Screens for drug duplications with abuse potential
• Improves both clinical and financial outcomes by avoiding toxic or unnecessary therapies
• Reduces risks by protecting against unintentional drug duplication associated with the combined use of prescription and OTC medications
• Enhances the safety of patients being treated by multiple physicians
• Click here to download the PDF

FOR PAYERS

• Supports Drug Utilization Review (DUR)
• Identifies duplications related to ingredients, actions or indications
• Screens for drug duplications with abuse potential
• Improves both clinical and financial outcomes by avoiding toxic or unnecessary therapies
• Reduces risks by protecting against unintentional drug duplication associated with the combined use of prescription and OTC medications
• Enhances the safety of patients being treated by multiple physicians
• Click here to download the PDF

FOR PHARMACISTS

• Supports Drug Utilization Review (DUR)
• Identifies duplications related to ingredients, actions or indications
• Screens for drug duplications with abuse potential
• Improves both clinical and financial outcomes by avoiding toxic or unnecessary therapies
• Reduces risks by protecting against unintentional drug duplication associated with the combined use of prescription and OTC medications
• Enhances the safety of patients being treated by multiple physicians
• Click here to download the PDF

This product is produced and delivered to customers on a weekly, monthly or quarterly basis.